Page 3 - Phillip Sharp News Today

Shares of Biogen soared 9.5 percent

Biogen Inc shares jumped by the most since the company’s Alzheimer’s disease treatment was approved in the US early this year, after a South Korean media report that it was in talks to sell itself to Samsung Group. The Korea Economic Daily reported that the US biotechnology company had approached the Seoul conglomerate about a takeover, citing unnamed sources. The report said that Biogen has posted relatively stable revenue in comparison with “cyclical industries like semiconductors,” wh...

Shares of Biogen surged on Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than $40 bi

We learn about what it takes to become a laureate of the prestigious Nobel Prize

The Richard Nixon Foundation will host the Nixon National Cancer Conference at the Richard Nixon Presidential Library and

The Fort Bend ISD Board of Trustees has taken the unusual step of rebuking one of its own, accusing trustee Denetta Williams of abusing a former employee, sharing confidential information

Why they are so prestigious, and the background of some of the previous winners.

Why they are so prestigious, and the background of some of the previous winners.

Biogen and Envisagenics to advance RNA splicing research for CNS diseases Envisagenics’ SpliceCore platform can be used to identify, test and validate RNA splicing errors at scale Biogen and Envisagenics are collaborating to advance ribonucleic acid (RNA) splicing research within the central nervous system (CNS) diseases area. Biogen will utilise Envisagenics’ artificial-intelligence (AI)-driven RNA splicing platform – known as SpliceCore – in order to define and gain an understanding ...

Investegate announcements from Biogen Inc.; Envisagenics, Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research